Both sales and profit progressed as expected. Maintained growth along the existing growth curve

For the 1st quarter of FY12/2023, both sales and profit progressed steadily as expected, despite the drop in vaccination-related business following the rapid increase in the same period of the previous fiscal year and effects from cooling of enthusiasm for the fiscal year-end sales season for telecommunications infrastructure. New businesses, which has been a focus of our efforts since FY12/2022, grew and diversification of the client portfolio away from bias toward telecommunications infrastructure proceeded. The improvement in profitability through hybrid operation and organizational reinforcement also contributed to the solid performance against the full-year forecast. In the 2nd quarter and later, we will continue to pursue further progress without overlooking any new business trends in the post-COVID period.